Recently, the People’s Hospital of Nyingchi City sent a thank-you letter to Big Vision Medical, expressing gratitude for the fully automatic AI OCT donated by Big Vision Medical through the public welfare fund. It has provided stronger guarantees for the eye health of the people in the Nyingchi area, and promoted the application and popularization of advanced ophthalmic examination equipment in the Tibetan region. This not only embodies the concept of “Han and Tibetan are one family, hand in hand for common growth,” but also demonstrates Big Vision Medical’s commitment to undertaking social responsibilities and missions.
Nyingchi City is located in the southeastern part of Tibet, with an average elevation of 3100 meters, and is known by the beautiful names “Southern Jiangnan of Tibet” and “Pearl of the Snow Land.” In Nyingchi, the Yarlung Tsangpo River rushes through, and the Himalayas prop up the sky’s backbone. The unique geographical environment has endowed Nyingchi City with resilience and vitality, but it has also resulted in relatively scarce medical resources in the city.
However, the medical development of Nyingchi City has not been constrained by environmental factors. The People’s Hospital of Nyingchi City, established in 1966, has now become a comprehensive national tertiary Grade A hospital integrating medical treatment, prevention, health care, rehabilitation, emergency treatment, scientific research, and teaching. With the development of the times, the People’s Hospital of Nyingchi City has continuously improved its departmental system. As an important part of clinical medicine, ophthalmology has actively conducted early screening and diagnosis of fundus diseases through cooperation with well-known ophthalmic hospitals nationwide, providing modern and comprehensive eye health services for the people of Nyingchi.
Due to geographical and economic constraints, ophthalmic examination equipment, especially fundus examination equipment, is relatively scarce in the Nyingchi area, which has affected the further improvement of the hospital’s level of diagnosis and treatment of fundus diseases. As a pioneer in the AI ophthalmology industry, Bigway Medical has always been committed to empowering clinical diagnosis and treatment with AI, and promoting the improvement of primary medical capabilities. With the leadership of the public welfare fund, Bigway’s fully automatic AI OCT has been successfully deployed at the People’s Hospital of Nyingchi City, contributing to the cause of eye health for the people in border areas.
The shortage of ophthalmic diagnostic and treatment resources in border areas, similar to Nyingchi, is not an isolated case. Currently, there are challenges in ophthalmic medical services, including a high incidence of eye diseases, difficulty in detection, and a shortage of ophthalmologists. The combination of artificial intelligence and intelligent ophthalmic equipment can effectively address the severe shortage of ophthalmic medical resources in primary and border areas. Big Vision fully automatic AI OCT integrates the industry’s leading ophthalmic image-assisted diagnostic system, which not only accurately identifies, segments, and automatically labels lesion areas, enabling the immediate detection of fundus diseases, but also allows ophthalmologists to refer to AI analysis results for fundus image learning, thereby rapidly improving their diagnostic capabilities. This effectively alleviates the contradiction of the severe shortage of ophthalmic medical resources in primary and border areas.
Big Vision Medical also thanks the People’s Hospital of Nyingchi City for their recognition of Big Vision fully automatic AI OCT, which deeply reinforces Big Vision awareness that an excellent intelligent ophthalmic device can bring very effective assistance to the prevention and treatment of eye diseases for people in border areas. In the future, Big Vision will develop more advanced intelligent ophthalmic devices to comprehensively enhance the ophthalmic medical service capabilities in border and grassroots areas.
No comments yet.